Elicio Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -289 | -286 | -283 | -281 |
EBITDA | -11,127 | -7,095 | -9,374 | -10,086 |
EBIT | -11,416 | -7,381 | -9,657 | -10,367 |
Net Income | -11,823 | -7,718 | -10,083 | -10,561 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,645 | -6,813 | -11,086 | -8,950 |
Cash | 14,948 | 18,563 | 20,611 | 22,088 |
Basic Shares | 18,211 | 15,312 | 16,692 | 16,059 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,128 | -1,178 | -1,170 | -1,057 |
EBITDA | -37,310 | -50,265 | -32,966 | -23,554 |
EBIT | -38,438 | -51,443 | -34,136 | -24,611 |
Net Income | -39,571 | -51,898 | -35,195 | -28,208 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -36,968 | -37,155 | -32,760 | -22,833 |
Cash | 18,563 | 17,618 | 12,894 | 7,797 |
Basic Shares | 15,312 | 12,202 | 5,056 | 3,100 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.65 |
2025-12-31 | -$0.49 |
2025-09-30 | -$0.60 |
2025-06-30 | -$0.66 |